Real-World Efficacy and Safety of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma: Nationwide Retrospective Analysis of the Named Patient Program in Korea.
Saved in:
| Title: | Real-World Efficacy and Safety of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma: Nationwide Retrospective Analysis of the Named Patient Program in Korea. |
|---|---|
| Authors: | Yi, Jun Ho1 (AUTHOR), Lee, Jae Hoon2 (AUTHOR), Jung, Sung‑Hoon3 (AUTHOR), Lee, Ji Hyun4 (AUTHOR), Lee, Ji Yun5 (AUTHOR), Kim, Kihyun6 (AUTHOR), Park, Sung‑Soo7 (AUTHOR), Min, Chang‑Ki7 (AUTHOR), Choi, Yoon Seok8 (AUTHOR), Kim, Min Kyoung9 (AUTHOR), Yhim, Ho-Young10 (AUTHOR), Yoon, Dok Hyun11 (AUTHOR) dhyoon@amc.seoul.kr |
| Source: | Cancer Research & Treatment. Jul2026, Vol. 58 Issue 3, p971-978. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 15982998 |
|---|---|
| DOI: | 10.4143/crt.2025.399 |
